Allergen-induced synthesis of F2-isoprostanes in atopic asthmatics: Evidence for oxidant stress

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 6, 1999, Pages 1947-1951

  Dworski, Ryszard ^a   Murray, John J ^a   Roberts II, L Jackson ^a   Oates, John A ^a   Morrow, Jason D ^a   Fisher, Laura ^a   Sheller, James R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CORTICOSTEROID; ISOPROSTANE;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; HUMAN; LIPID PEROXIDATION; LUNG LAVAGE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; PROVOCATION TEST; URINARY EXCRETION;

EID: 0033406396     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.6.9903064     Document Type: Article

References (35)

1. Beasley, R., W. R. Roche, J. A. Roberts, and S. T. Holgate. 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139:806-817.
2. Sedgwick, J. B., K. M. Geiger, and W. W. Busse. 1990. Superoxide generation by hypodense eosinophils from patients with asthma. Am. Rev. Respir. Dis. 142:120-125.
3. Calhoun, W. J., H. E. Reed, D. R. Moest, and C. A. Stevens. 1992. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. Am. Rev. Respir. Dis. 145:317-325.
4. Sanders, S. P., J. L. Zweier, S. J. Harrison, M. A. Trush, S. J. Rembish, and M. C. Liu. 1995. Spontaneous oxygen radical production at sites of antigen challenge in allergic subjects. Am. J. Respir. Crit. Care Med. 151:1725-1733.
5. Chihara, J., N. Hayashi, T. Kakazu, T. Yamamoto, D. Kurachi, and S. Nakajima. 1996. RANTES augments radical oxygen products from eosinophils. Intern. Arch. Allergy Immunol 104(Suppl.):52-53.
6. Tenscher, K., B. Metzner, E. Schopf, J. Norgauer, and W. Czech. 1996. Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood 88:3195-3199.
7. 4 formation and luminol dependent chemiluminescence of human eosinophils. Pharm. Res. Comm. 18:61-69.
8. De Raeve, H. R., F. B. J. M. Thunnissen, F. T. Kaneko, F. H. Guo, M. Lewis, M. S. Kavuru, M. Secic, M. J. Thomassen, and S. C. Erzurum. 1997. Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo. Am. J. Physiol. 272:L148-L154.
9. Saleh, D., P. Ernst, S. Lim, P. J. Barnes, and A. Giaid. 1998. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J. 12:929-937.
10. Kharitonov, S. A., D. Yates, R. A. Robbins, R. Logan-Sinclair, E. A. Shinebourne, and P. J. Barnes. 1994. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343:133-135.
11. Mustafa, M. G. 1990. Biochemial basis of ozone toxicity. Free Rad. Biol. Med. 9:245-265.
12. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U.S.A. 87:9383-9387.
13. Morrow, J. D., and L. J. Roberts, II. 1997. The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid Res. 36:1-21.
14. 2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. U.S.A. 89:10721-10725.
15. 2α in the airways of human subjects. Am. J. Respir. Cell Mol. Biol. 9:568-572.
16. Montuschi, P., G. Ciabattoni, P. Paredi, P. Pantelidis, R. M. Du Bois, S. A. Kharitonov, and P. J. Barnes. 1998. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am. J. Respir. Crit. Care Med. 158:1524-1527.
17. 2α-III, an index of oxidant stress. Am. J. Respir. Crit. Care Med. 158:1709-1714.
18. Sladek, K., R. Dworski, G. A. FitzGerald, K. L. Buitkus, F. J. Block, S. R. Marney, Jr., and J. R. Sheller. 1990. Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Am. Rev. Respir. Dis. 141:1441-1445.
19. Kane, G. C., M. Pollice, M. Kim, C. J. Cohn, R. Dworski, J. J. Murray, J. Sheller, J. E. Fish, and S. P. Peters. 1966. A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge. J. Allergy Clin. Immunol. 97:646-654.
20. 2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzym. 300:3-12.
21. 2 by a stable isotope dilution mass spectrometric assay. Anal. Biochem. 193:142-148.
22. 2 alpha. J. Biol. Chem. 270:9800-9808.
23. Halliwell, B., and S. Chirico. 1993. Lipid peroxidation: its mechanism, measurement, and significance. Am. J. Clin. Nutr. 57(Suppl.):715S-725S.
24. Dohlman, A. W., H. R. Black, and J. A. Royall. 1993. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients. Am. Rev. Respir. Dis. 148:955-960.
25. Jarjour, N. N., W. W. Busse, and W. J. Calhoun. 1992. Enhanced production of oxygen radicals in nocturnal asthma. Am. Rev. Respir. Dis. 146:905-911.
26. Antczak, A., D. Nowak, D., B. Shariati, M. Król, G. Piasecka, and Z. Kurmanowska. 1997. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur. Respir. J. 10:1235-1241.
27. Murray, J. J., D. D. Hagaman, R. Dworski, B. Keane, and J. R. Sheller. 1988. Inhibition by salmeterol and beclomethasone of late phase response to segmental antigen challenge in asthmatics (abstract). Am. J. Respir. Crit. Care Med. 157:A872.
28. 2α, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am. J. Respir. Crit. Care Med. 153:590-596.
29. 2α induces airflow obstruction and airway plasma exudation in vivo. Am. J. Respir. Crit. Care Med. 155:436-441.
30. 2α in rabbit lung in situ. Am. J. Physiol. 263:H660-H663.
31. 2α-III, induce cardiomyocyte hypertrophy. J. Biol. Chem. 273:22442-22452.
32. Suzuki, Y. J., H. F. Forman, and A. Sevanian. 1997. Oxidants as stimulators of signal transduction. J. Free Rad. Biol. Med. 22:269-285.
33. 2 activity: membrane effects versus enzyme phosphorylation. Arch. Biochem. Biophys. 343:44-54.
34. Leonardduzzi, G., A. Scavazza, F. Biasi, E. Chiarpotto, S. Camandola, S. Vogl, R. Dargel, and G. Poli. 1997. The lipid peroxidation end product 4-hydroxy-2-3-nonenal up-regulates transforming growth factor β1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J. 11:851-857.
35. Kramer, K., B. Rademaker, W.H. Rozendal, H. Timmerman, and A. Bast. 1986. Influence of lipid peroxidation on beta-adrenoceptors. FEBS Lett. 198:80-84.